Cochrane Heart Protocols Published with BHF CRC Support

Photos,Of,Charts,,Diagrams,And,Numbers,Showing,The,Rise,And

Two Cochrane Heart protocols have recently been published, with support from teams provided by the BHF CRC.  ‘Transcatheter and surgical intervention for secondary mitral regurgitation’ and  ‘Catheter ablation versus escalation of antiarrhythmic medications for management of ventricular tachycardia in patients with ischaemic heart disease

Both titles have resulted from the hard work of many of the BHF CRC’s research group members and they are a great testament to the value that has been derived from our links with Cochrane Heart.  Early in its development, the BHF CRC recognised the potential that a partnership with Cochrane heart would bring to both parties, with the BHF CRC providing expert teams from our research groups to lead systematic reviews and Cochrane working closely with these teams, providing training and support for high profile systematic reviews. Included in this is the recent Covid review whereby a team was assembled quickly from the CRC. This included 220 studies and was done within a few months; it already has 29 citations, has been translated into 6 languages and involved authors from nearly every member society of the BHF CRC. 

Partnership with the Cochrane Heart Group continues to thrive and we have provided 10 expert teams from our research groups to lead the systematic reviews in the following ten titles:

  • Interventions for alcohol cessation in people with atrial fibrillation
  • Association of aspirin and anticoagulants for secondary prevention of cardiovascular disease
  • Automatic external defibrillators for preventing sudden cardiac death
  • Risk factor modification for the management of atrial fibrillation
  • Percutaneous versus surgical intervention for mitral regurgitation
  • Catheter ablation for atrial fibrillation
  • De-escalation of dual antiplatelet therapy for patients with acute coronary syndrome after percutaneous coronary intervention: a network meta-analysis of randomised controlled trials
  • Pharmacological interventions for the prevention and treatment of aortic root and heart valve disease
  • COVID-19 and its cardiovascular effects: a systematic review of prevalence studies

Share this article

Facebook
Twitter
LinkedIn